TMCnet News
Global Cancer Diagnostics Device Market to Grow 18.07% by 2020 - Key Vendors are Agilent Technologies, Qiagen & Roche Diagnostics - Research and MarketsResearch and Markets has announced the addition of the "Global Cancer Diagnostics Device Market 2016-2020" report to their offering. The report forecasts the global cancer diagnostics devices market to grow at a CAGR of 18.07% during the period 2016-2020. The report has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects over the coming years. The report also includes a discussion of the key vendors operating in this market. A trend which will definitely boost market growth is product approvals and launches. The significant focus on cancer diagnosis has led to the development of novel cancer diagnostic devices in the market. Many of these products have received approval from regulatory agencies such as the FDA and Health Canada. The availability of these advanced tests and associated diagnostic devices has allowed medical facilities to adopt them for cancer diagnosis. Accordin to the report, a key growth driver is the demand for personalized medicines. The production of personalized drugs depends on the identification and study of protein and gene expressions. These drugs are customized based on an individual's protein or genetic profiles. Personalized medicines have high demand in oncology therapy since conventional cancer drug therapies fail to achieve desired patient outcomes. Further, the report states that one challenge that could impact market growth is the high cost of developing companion diagnostics. Key vendors: Key Topics Covered: PART 01: Executive summary PART 02: Scope of the report PART 03: Market research methodology PART 04: Introduction PART 05: Cancer statistics PART 06: Market landscape PART 07: Reimbursement and coverage: An overview PART 08: Cancer diagnostic devices: Pricing scenario PART 09: Market segmentation by product PART 10: Market segmentation by cancer type PART 11: Geographical segmentation PART 12: Market drivers PART 13: Impact of drivers PART 14: Market challenges PART 15: Impact of drivers and challenges PART 16: Market trends PART 17: Vendor landscape PART 18: Key vendors PART 19: Appendix For more information visit http://www.researchandmarkets.com/research/zrvp5c/global_cancer View source version on businesswire.com: http://www.businesswire.com/news/home/20160708005284/en/ |